Johnson & Johnson says it will stop selling talc-based baby powder globally in 2023, more than two years after it ended US sales of a product that has drawn thousands of consumer safety lawsuits.
Johnson & Johnson (JNJ.N) will stop selling talc-based baby powder globally in 2023, the drugmaker said on Thursday, more than two years after it ended US sales of a product that drew thousands of consumer safety lawsuits.
Pharmaceuticals giant Johnson & Johnson will stop selling its trademark talc-based baby powder worldwide as the company pays out billions of dollars to women claiming it causes cancer